Donate

News

Latest news

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

January 20, 2021,

Smoldering multiple myeloma 40 years later: a story of unintended disease

January 13, 2021,

Higher Rates of COVID-19 Mortality for Patients with Multiple Myeloma

January 8, 2021, ,

Saad Z. Usmani, MD, MBA, FACP, on the Latest in Multiple Myeloma Research

January 7, 2021,

Insurance Status Linked to Survival for Patients with Multiple Myeloma

January 5, 2021,

A Beginner’s Guide to Understanding Myeloma

December 21, 2020,

Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

December 16, 2020,

Subcut daratumumab: reducing treatment burden in myeloma

December 11, 2020, ,

Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma

December 10, 2020,

Year in Review: Multiple Myeloma

December 3, 2020,

Myeloma Research Review – issue 36

December 2, 2020,

Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

December 2, 2020, ,

Newsletter: Summer 2020

December 1, 2020,

MM management in Australia lags behind other countries due to reimbursement model

November 18, 2020,

Bridging Radiation Therapy Safe, Feasible for Patients with R/R Multiple Myeloma

November 17, 2020,

Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma

November 13, 2020, ,

Multiple myeloma-A painful disease of the bone marrow

November 10, 2020,

Hamilton Myeloma Seminar – 28 November

November 9, 2020,

Hematologist Discusses the Multiple Myeloma Pipeline

November 6, 2020,

Saad Usmani Discusses Treatments in Multiple Myeloma Patients.

November 5, 2020,

A Look at the Immunotherapy Pipeline for Multiple Myeloma

November 2, 2020,

Whangarei Myeloma Seminar – 23 November

October 26, 2020,

Optimal Strategies for Treatment of Multiple Myeloma in Newly Diagnosed Patients

October 12, 2020,

Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay

October 12, 2020,

Chatham cancer survivor inspires multiple myeloma patients

October 2, 2020,

Multiple Myeloma March tackles low awareness, boosts research

September 30, 2020

New partnership aims to advance predictive tests for multiple myeloma in Ireland

September 21, 2020,

Crohn’s and Colitis NZ patient support group requests your support

September 21, 2020

New myeloma study

September 21, 2020

Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19

September 18, 2020,

Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma

September 18, 2020,

Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma

September 18, 2020,

Despite COVID-19 limitations, fundraiser for multiple myeloma finds a way

September 14, 2020, ,

NICE turns down Celgene’s Revlimid as multiple myeloma maintenance treatment

September 10, 2020,

Blood Cancer Awareness Month

September 7, 2020,

Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay

September 4, 2020,

Newsletter: Spring 2020

August 28, 2020

Learning About Resources in Multiple Myeloma

August 27, 2020,

Changing Patterns of Care in Multiple Myeloma

August 27, 2020,

FDA Approves Daratumumab, Carfilzomib, Dexamethasone Triplet to Treat Multiple Myeloma

August 24, 2020,

COVID-19: Rates of Hospitalization and Mortality Among Patients With Multiple Myeloma

August 20, 2020, ,

Berdeja Compares Later-Line Therapies in Multiple Myeloma

August 20, 2020,

MRD, Biomarkers in Multiple Myeloma

August 17, 2020,

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

August 13, 2020,

Exploring Challenges With CAR T Cells and NK Cells in Multiple Myeloma

August 11, 2020,

Upcoming patient seminar: Hamilton

August 11, 2020,

GSK nabs FDA approval for first-in-class multiple myeloma drug

August 7, 2020,

Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma

August 6, 2020,

“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes

August 4, 2020,

Severe Renal Impairment Worsens Outcomes in Multiple Myeloma

August 3, 2020,